Search hospitals > Louisiana > New Orleans
Ochsner Medical Center Jefferson
Claim this profileNew Orleans, Louisiana 70121
Global Leader in Cancer
Global Leader in Parotid Gland Cancer
Conducts research for Breast Cancer
Conducts research for Lymphoma
Conducts research for Adult T-Cell Leukemia/Lymphoma
575 reported clinical trials
69 medical researchers
Summary
Ochsner Medical Center Jefferson is a medical facility located in New Orleans, Louisiana. This center is recognized for care of Cancer, Parotid Gland Cancer, Breast Cancer, Lymphoma, Adult T-Cell Leukemia/Lymphoma and other specialties. Ochsner Medical Center Jefferson is involved with conducting 575 clinical trials across 1,029 conditions. There are 69 research doctors associated with this hospital, such as Craig Lotterman, Marc Matrana, MD, Jonathan Mizrahi, MD, and Daniel Johnson, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage I
Stage II
2Parotid Gland Cancer
Global LeaderStage IV
Stage III
Stage I
Top PIs
Craig LottermanOchsner Medical Center Jefferson8 years of reported clinical research
Expert in Cancer
Expert in Lymphoma
54 reported clinical trials
102 drugs studied
Marc Matrana, MDOchsner Medical Center Jefferson5 years of reported clinical research
Expert in Lung Cancer
Studies Non-Small Cell Lung Cancer
26 reported clinical trials
65 drugs studied
Jonathan Mizrahi, MDOchsner Medical Center Jefferson4 years of reported clinical research
Studies Pancreatic Cancer
Studies Colorectal Cancer
12 reported clinical trials
26 drugs studied
Daniel Johnson, MDOchsner Clinic Foundation7 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
11 reported clinical trials
27 drugs studied
Clinical Trials running at Ochsner Medical Center Jefferson
Bladder Cancer
Cancer
Breast Cancer
Ovarian Cancer
Lung Cancer
Parotid Gland Cancer
Non-Small Cell Lung Cancer
Bladder Carcinoma
Breast cancer
Prostate Cancer
TAR-210
for Bladder Cancer
The main purpose of this study is to compare the disease-free survival between participants receiving treatment with TAR-210 versus investigator's choice of intravesical chemotherapy for treatment of intermediate-risk NMIBC.
Recruiting2 awards Phase 34 criteria
Blood Test and Immunotherapy
for Bladder Cancer
This phase II/III trial examines whether patients who have undergone surgical removal of bladder, kidney, ureter or urethra, but require an additional treatment called immunotherapy to help prevent their urinary tract (urothelial) cancer from coming back, can be identified by a blood test. Many types of tumors tend to lose cells or release different types of cellular products including their DNA which is referred to as circulating tumor DNA (ctDNA) into the bloodstream before changes can be seen on scans. Health care providers can measure the level of ctDNA in blood or other bodily fluids to determine which patients are at higher risk for disease progression or relapse. In this study, a blood test is used to measure ctDNA and see if there is still cancer somewhere in the body after surgery and if giving a treatment will help eliminate the cancer. Immunotherapy with monoclonal antibodies, such as nivolumab and relatlimab, can help the body's immune system to attack the cancer, and can interfere with the ability of tumor cells to grow and spread. This trial may help doctors determine if ctDNA measurement in blood can better identify patients that need additional treatment, if treatment with nivolumab prolongs patients' life and whether the additional immunotherapy treatment with relatlimab extends time without disease progression or prolongs life of urothelial cancer patients who have undergone surgical removal of their bladder, kidney, ureter or urethra.
Recruiting1 award Phase 2 & 310 criteria
Gemcitabine + Cisplatin
for Bladder Cancer
This phase II trial studies how well gemcitabine hydrochloride and cisplatin work in treating participants with invasive bladder urothelial cancer. Drugs used in chemotherapy, such as gemcitabine hydrochloride and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading.
Recruiting1 award Phase 2
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Ochsner Medical Center Jefferson?
Where is Ochsner Medical Center Jefferson located?
Who should I call to ask about financial aid or insurance network?
What insurance does Ochsner Medical Center Jefferson accept?
What awards or recognition has Ochsner Medical Center Jefferson received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.